Kestra Advisory Services’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Kestra Advisory Services’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,800	Closed	-$9K	–	2378
2022 Q3	$9K	Sell	33,800 -500	-1%	-$218	﹤0.01%	2084
2022 Q2	$26K	Buy	34,300 +600	+2%	+$535	﹤0.01%	2078
2022 Q1	$36K	Buy	33,700 +5,700	+20%	+$10.4K	﹤0.01%	1974
2021 Q4	$53K	Buy	+28,000	New	+$67.1K	﹤0.01%	1972

Kestra Advisory Services's AGTC Position: Q4 2022 in Review

Kestra Advisory Services sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 33,800 shares — an estimated $9K sold.

Kestra Advisory Services first reported a position in AGTC in Q4 2021 and held it in 4 quarters. The position peaked at $53K in Q4 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

Kestra Advisory Services reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
Kestra Advisory Services sold 33,800 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $9K.
Kestra Advisory Services first reported a position in Applied Genetic Technologies Corporation in Q4 2021 and held it in 4 quarters.
Kestra Advisory Services's Applied Genetic Technologies Corporation position peaked at $53K in Q4 2021.
0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Kestra Advisory Services's 13F filing for Q4 2022, filed 31 Jan 2023.